Related Materials - European Society of Cardiology

ESC/EACTS Page 8 of 34
adverse outcomes with bypass: outcome of diabetic patients in
the AWESOME randomized trial and registry. J Am Coll Cardiol
2002;40(9):1555-1566.
Serruys P. Two-year outcomes from the SYNTAX trial. 2009 Sep 21;
ESC Congress 2009 Sep 21; http://www.escardio.org/congresses/
esc-2009/congress-topic/Pages/Interventional-cardiology.aspx .
Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A,
Bonnier JJ, Schonberger JP, Buller N, Bonser R, Disco C, Backx
B, Hugenholtz PG, Firth BG, Unger F. Five-year outcomes after
coronary stenting versus bypass surgery for the treatment
of multivessel disease: the final analysis of the Arterial
Revascularization Therapies Study (ARTS) randomized trial. J Am
Coll Cardiol 2005;46(4):575-581.
Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Miller DD.
Prognostic value of dipyridamole technetium-99m sestamibi
myocardial tomography in patients with stable chest pain who are
unable to exercise. Am J Cardiol 1994;73(9):647-652.
Tarakji KG, Brunken R, McCarthy PM, Al-Chekakie MO, Abdel-
Latif A, Pothier CE, Blackstone EH, Lauer MS. Myocardial
viability testing and the effect of early intervention in patients
with advanced left ventricular systolic dysfunction. Circulation
2006;113(2):230-237.
Tsuyuki RT, Shrive FM, Galbraith PD, Knudtson ML, Graham
MM. Revascularization in patients with heart failure. CMAJ
2006;175(4):361-365.
Valgimigli M, Malagutti P, Rodriguez-Granillo GA, Garcia-Garcia
HM, Polad J, Tsuchida K, Regar E, Van der Giessen WJ, de JP,
De FP, Serruys PW. Distal left main coronary disease is a major
predictor of outcome in patients undergoing percutaneous
intervention in the drug-eluting stent era: an integrated clinical
and angiographic analysis based on the Rapamycin-Eluting Stent
Evaluated At Rotterdam Cardiology Hospital (RESEARCH)
and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital
(T-SEARCH) registries. J Am Coll Cardiol 2006;47(8):1530-1537.
Wijeysundera HC, Ko DT. Does percutaneous coronary
intervention reduce mortality in patients with stable chronic
angina: are we talking about apples and oranges? Circ Cardiovasc
Qual Outcomes 2009;2(2):123-126.
7. Revascularisation in Non STsegment
Elevation Acute Coronary
Syndromes
de Winter RJ, Windhausen F, Cornel JH, Dunselman PH, Janus CL,
Bendermacher PE, Michels HR, Sanders GT, Tijssen JG, Verheugt
FW. Early invasive versus selectively invasive management for
acute coronary syndromes. N Engl J Med 2005;353(11):1095-
1104.
Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC,
Chamberlain DA, Shaw TR, Wheatley DJ, Pocock SJ. Interventional
versus conservative treatment for patients with unstable angina
or non-ST-elevation myocardial infarction: the British Heart
Foundation RITA 3 randomised trial. Randomized Intervention
Trial of unstable Angina. Lancet 2002;360(9335):743-751.
Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E, Wallentin L.
5-year outcomes in the FRISC-II randomised trial of an invasive
versus a non-invasive strategy in non-ST-elevation acute coronary
syndrome: a follow-up study. Lancet 2006;368(9540):998-1004.
7.1 Intended early invasive or conservative
strategies
Bavry AA, Kumbhani DJ, Rassi AN, Bhatt DL, Askari AT. Benefit
of early invasive therapy in acute coronary syndromes: a metaanalysis
of contemporary randomized clinical trials. J Am Coll
Cardiol 2006;48(7):1319-1325.
Cannon CP. Revascularisation for everyone? Eur Heart J
2004;25(17):1471-1472.
de Winter RJ, Windhausen F, Cornel JH, Dunselman PH, Janus CL,
Bendermacher PE, Michels HR, Sanders GT, Tijssen JG, Verheugt
FW. Early invasive versus selectively invasive management for
acute coronary syndromes. N Engl J Med 2005;353(11):1095-
1104.
Ottervanger JP, Armstrong P, Barnathan ES, Boersma E, Cooper
JS, Ohman EM, James S, Topol E, Wallentin L, Simoons ML. Longterm
results after the glycoprotein IIb/IIIa inhibitor abciximab in
unstable angina: one-year survival in the GUSTO IV-ACS (Global
Use of Strategies To Open Occluded Coronary Arteries IV--Acute
Coronary Syndrome) Trial. Circulation 2003;107(3):437-442.
7.2 Risk stratification
Diderholm E, Andren B, Frostfeldt G, Genberg M, Jernberg T,
Lagerqvist B, Lindahl B, Venge P, Wallentin L. The prognostic
and therapeutic implications of increased troponin T levels and
ST depression in unstable coronary artery disease: the FRISC
II invasive troponin T electrocardiogram substudy. Am Heart J
2002;143(5):760-767.
Diderholm E, Andren B, Frostfeldt G, Genberg M, Jernberg T,
Lagerqvist B, Lindahl B, Wallentin L. ST depression in ECG at entry
indicates severe coronary lesions and large benefits of an early
invasive treatment strategy in unstable coronary artery disease;
the FRISC II ECG substudy. The Fast Revascularisation during
InStability in Coronary artery disease. Eur Heart J 2002;23(1):41-
49.
Gale CP, Manda SO, Weston CF, Birkhead JS, Batin PD, Hall AS.
Evaluation of risk scores for risk stratification of acute coronary
syndromes in the Myocardial Infarction National Audit Project
(MINAP) database. Heart 2009;95(3):221-227.
Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon
CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox
KA. Predictors of hospital mortality in the global registry of acute
coronary events. Arch Intern Med 2003;163(19):2345-2353.
James SK, Lindback J, Tilly J, Siegbahn A, Venge P, Armstrong P, Califf
R, Simoons ML, Wallentin L, Lindahl B. Troponin-T and N-terminal
pro-B-type natriuretic peptide predict mortality benefit from
coronary revascularization in acute coronary syndromes: a
GUSTO-IV substudy. J Am Coll Cardiol 2006;48(6):1146-1154.
Jernberg T, Lindahl B, Siegbahn A, Andren B, Frostfeldt G,
Lagerqvist B, Stridsberg M, Venge P, Wallentin L. N-terminal probrain
natriuretic peptide in relation to inflammation, myocardial
necrosis, and the effect of an invasive strategy in unstable coronary
artery disease. J Am Coll Cardiol 2003;42(11):1909-1916.
Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus
femoral access for coronary angiography or intervention and the
impact on major bleeding and ischemic events: a systematic review
and meta-analysis of randomized trials. Am Heart J 2009;157:132-
140.
Lagerqvist B, Diderholm E, Lindahl B, Husted S, Kontny F, Stahle
E, Swahn E, Venge P, Siegbahn A, Wallentin L. FRISC score for
selection of patients for an early invasive treatment strategy in
unstable coronary artery disease. Heart 2005;91(8):1047-1052.
Lindahl B, Diderholm E, Lagerqvist B, Venge P, Wallentin L.
Mechanisms behind the prognostic value of troponin T in unstable